IJ Pharmaceutical Research
Scopus by Title (Ref)
1. Prevalence and genotype distribution of human papillomavirus in individuals referred to a laboratory in Urmia, Iran
- Mojarrad S. , et al.
2. Cost-effectiveness analysis of different types of human papillomavirus vaccination to prevent cervical cancer in Iran
- Bashari N. , et al.
3. Uncommon high distribution of HPV-16, HPV-54, and HPV-56 in female referred to a laboratory in Karaj, Iran: indications of a paradigm shift in HPV genotypes?
- Letafati A. , et al.
4. Challenges and Barriers to Human Papillomavirus Vaccination in Women of Reproductive Age Based on the Health Belief Model: A Systematic Review
- Alizadeh L. , et al.
5. The 15-year national trends of genital cancer incidence among Iranian men and women; 2005–2020
- Shafiee G. , et al.
6. Barriers to the HPV vaccination program in the Eastern Mediterranean region: a narrative review
- Hakimi S. , et al.
7. Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective
- Ebrahimi N. , et al.
8. Designing and psychometric assessment of the scale of factors influencing HPV vaccine uptake behaviors in young adults
- Yarmohammadi S. , et al.
9. Strategies for improving participation in human papillomavirus vaccination among young adults in the capital of Iran: A qualitative-exploratory study
- Yarmohammadi S. , et al.
10. QALY league table of Iran: a practical method for better resource allocation
- Hashempour R. , et al.
11. Mothers’ preferences and willingness-to-pay for human papillomavirus vaccines in Iran: A discrete choice experiment study
- Sargazi N. , et al.
12. A systematic review of economic evaluations of vaccines in Middle East and North Africa countries: is existing evidence good enough to support policy decision-making?
- Nagi M.A. , et al.
13. Factors Influencing the Cost-Effectiveness Outcomes of HPV Vaccination and Screening Interventions in Low-to-Middle-Income Countries (LMICs): A Systematic Review
- Okeah B.O. , et al.
14. Economic evaluation of human papillomavirus vaccination in the Global South: a systematic review
- Abidi S. , et al.
15. National and subnational trends of incidence and mortality of female genital cancers in Iran; 1990-2016
- Eftekharzadeh S. , et al.
16. Utilization evaluation of human papilloma virus vaccine (GARDASIL®) in Iran; A cross-sectional study
- Mohammadpour F. , et al.
17. Effects of group training based on the health belief model on knowledge and behavior regarding the Pap smear test in Iranian Women: A Quasi-experimental study
- Shobeiri F. , et al.
18. Cervical cancer in Iran: Integrative insights of epidemiological analysis
- Momenimovahed Z. , et al.
19. Cost-Effectiveness Analysis of the Introduction of HPV Vaccination of 9-Year-Old-Girls in Iran
- Yaghoubi M. , et al.
20. Challenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations
- Ekwunife O.I. , et al.
21. The role of human papilloma virus (HPV) vaccines in prevention of cervical cancer
- Mofrad M.H. , et al.
22. Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: Systematic review and economic evaluation
- Thurgar E. , et al.
23. Cost-effectiveness analysis of biogeneric recombinant activated factor VII (AryoSeven™) and activated prothrombin complex concentrates (FEIBA™) to treat hemophilia a patients with inhibitors in Iran
- Golestani M. , et al.
24. Effects of group training based on the health belief model on knowledge and behavior regarding the pap smear test in iranian women: A quasi-experimental study
- Shobeiri F. , et al.
25. Priority setting for improvement of cervical cancer prevention in Iran
- Majidi A. , et al.